Back
Day Range
$4.18
$4.29
52-Week Range
$3.17
$5.50
Volume
1,773
50D / 200D Avg
$4.46
/
$4.48
Prev Close
$4.08
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.5 | 0.4 |
| P/B | 0.2 | 2.9 |
| ROE % | 9.7 | 3.8 |
| Net Margin % | 15.5 | 3.9 |
| Rev Growth 5Y % | 6.7 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 6.71% annually over 5 years — modest growth
Earnings declined -10.86% over the past year
Net margin of 15.53% shows strong profitability
Generating 1.78B in free cash flow
P/E of 2.49 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.26%
Growth
Revenue Growth (5Y)
6.71%
Revenue (1Y)3.45%
Earnings (1Y)-10.86%
FCF Growth (3Y)5.88%
Quality
Return on Equity
9.71%
ROIC5.96%
Net Margin15.53%
Op. Margin22.57%
Safety
Debt / Equity
0.75
Current Ratio1.47
Interest Coverage1.67
Valuation
P/E Ratio
2.49
P/B Ratio0.24
EV/EBITDA6.14
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.45% | Revenue Growth (3Y) | -1.37% |
| Earnings Growth (1Y) | -10.86% | Earnings Growth (3Y) | -14.83% |
| Revenue Growth (5Y) | 6.71% | Earnings Growth (5Y) | -2.64% |
| Profitability | |||
| Revenue (TTM) | 7.70B | Net Income (TTM) | 1.20B |
| ROE | 9.71% | ROA | 4.75% |
| Gross Margin | 59.04% | Operating Margin | 22.57% |
| Net Margin | 15.53% | Free Cash Flow (TTM) | 1.78B |
| ROIC | 5.96% | FCF Growth (3Y) | 5.88% |
| Safety | |||
| Debt / Equity | 0.75 | Current Ratio | 1.47 |
| Interest Coverage | 1.67 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 2.49 | P/B Ratio | 0.24 |
| P/S Ratio | 0.39 | PEG Ratio | -1.11 |
| EV/EBITDA | 6.14 | Dividend Yield | 0.04% |
| Market Cap | 2.98B | Enterprise Value | 10.67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.70B | 7.44B | 7.91B | 7.55B | 5.94B |
| Net Income | 1.20B | 1.34B | 1.65B | 1.70B | 1.33B |
| EPS (Diluted) | 1.89 | 2.10 | 2.58 | 2.65 | 2.08 |
| Gross Profit | 4.55B | 4.38B | 5.00B | 4.76B | 3.80B |
| Operating Income | 1.74B | 1.80B | 2.29B | 2.64B | 2.04B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 25.16B | 24.56B | 24.51B | 23.76B | 19.82B |
| Total Liabilities | 12.63B | 12.46B | 12.99B | 13.10B | 9.98B |
| Shareholders' Equity | 12.52B | 12.10B | 11.50B | 10.65B | 9.83B |
| Total Debt | 9.34B | 9.40B | 9.96B | 9.68B | 7.41B |
| Cash & Equivalents | 1.65B | 1.74B | 2.58B | 2.86B | 2.29B |
| Current Assets | 6.05B | 6.68B | 8.08B | 8.53B | 6.49B |
| Current Liabilities | 4.11B | 3.94B | 4.64B | 5.23B | 2.78B |